Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Bethany Sawchyn"'
Autor:
Coren A. Milbury, James Creeden, Wai-Ki Yip, David L. Smith, Varun Pattani, Kristi Maxwell, Bethany Sawchyn, Ole Gjoerup, Wei Meng, Joel Skoletsky, Alvin D. Concepcion, Yanhua Tang, Xiaobo Bai, Ninad Dewal, Pei Ma, Shannon T. Bailey, James Thornton, Dean C. Pavlick, Garrett M. Frampton, Daniel Lieber, Jared White, Christine Burns, Christine Vietz
Publikováno v:
PLoS ONE, Vol 17, Iss 3 (2022)
FoundationOne®CDx (F1CDx) is a United States (US) Food and Drug Administration (FDA)-approved companion diagnostic test to identify patients who may benefit from treatment in accordance with the approved therapeutic product labeling for 28 drug ther
Externí odkaz:
https://doaj.org/article/c077dd424a014a30b87dd38f621e7d50
Autor:
Rachel Cunningham, Michael J. Harvey, Meagan Montesion, Ali McBride, Bethany Sawchyn, Anita Chawla, Prasanth Reddy
Publikováno v:
JCO Precision Oncology. :1611-1624
PURPOSE This study assessed the economic impact of increased use of comprehensive genomic profiling (CGP) versus conventional testing strategies among patients with advanced non–small-cell lung cancer (aNSCLC) from a US commercial health plan persp
Autor:
Coren A. Milbury, James Creeden, Wai-Ki Yip, David L. Smith, Varun Pattani, Kristi Maxwell, Bethany Sawchyn, Ole Gjoerup, Wei Meng, Joel Skoletsky, Alvin D. Concepcion, Yanhua Tang, Xiaobo Bai, Ninad Dewal, Pei Ma, Shannon T. Bailey, James Thornton, Dean C. Pavlick, Garrett M. Frampton, Daniel Lieber, Jared White, Christine Burns, Christine Vietz
Publikováno v:
PloS one. 17(3)
FoundationOne®CDx (F1CDx) is a United States (US) Food and Drug Administration (FDA)-approved companion diagnostic test to identify patients who may benefit from treatment in accordance with the approved therapeutic product labeling for 28 drug ther
Autor:
Kristi Maxwell, Meagan Montesion, Bethany Sawchyn, Rachel Anhorn, Ingrid Marino, Eric Allan Severson
Publikováno v:
Journal of the National Comprehensive Cancer Network. 17:CGE19-064
Comprehensive genomic profiling (CGP) for patients with advanced solid tumors is on the trajectory of becoming standard of care through incorporation into clinical practice, professional society guidelines, availability of an FDA-approved assay, and
Publikováno v:
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 70(2)
Purpose Results of a study at two hospitals to validate and test systems for bar-code-assisted medication administration (BCMA) are reported, including data on bar-code scanning failures and BCMA-related staff resource needs. Methods To prepare for B
Autor:
Susan Gabriel, Kimberly Ruiz, Meryl Mendelson, Bethany Sawchyn, Jennifer A. Colby, Reynold A. Panettieri, Jonathan Corren
Publikováno v:
Journal of Allergy and Clinical Immunology. 137:AB26
Sarah W. Spriet, DO, Taylor A. Banks, MD, Cecilia Mikita, MD, MPH, FAAAAI; Walter Reed National Military Medical Center, Bethesda, MD. RATIONALE: Rabies post-exposure treatment is a medical necessity. Two rabies vaccines are available in the United S
Autor:
Meryl Mendelson, Jonathan Corren, Bethany Sawchyn, Kimberly Ruiz, Susan Gabriel, Jennifer A. Colby, Tom Karagiannis
Publikováno v:
Chest. 148:8A
Autor:
Jonathan Corren, Jennifer A. Colby, Susan Gabriel, Kimberly Ruiz, Bethany Sawchyn, Tom Karagiannis, Meryl Mendelson
Publikováno v:
Chest. 148:9A